High Effectiveness of a 14-Day Concomitant Therapy for <i>Helicobacter pylori</i> Treatment in Primary Care. An Observational Multicenter Study
Background: The current cure rates with triple therapy combining a proton-pump inhibitor, amoxicillin and clarithromycin are unacceptably low. Aims: To evaluate the efficacy of a 14-day concomitant therapy as an empirical first-line treatment for curing <i>Helicobacter pylori</i> (<i&...
Main Authors: | Llum Olmedo, Rafael Azagra, Amada Aguyé, Marta Pascual, Xavier Calvet, Emili Gené |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/8/2410 |
Similar Items
-
Comparative Efficacy of 14-Day Tegoprazan-Based Triple vs. 10-Day Tegoprazan-Based Concomitant Therapy for <i>Helicobacter pylori</i> Eradication
by: Chan Hyuk Park, et al.
Published: (2022-11-01) -
Effects of 14-days bismuth- and tetracycline-containing quadruple therapy with concomitant regimen for the first line Helicobacter pylori eradication
by: Arash Kazemi, et al.
Published: (2023-09-01) -
First-line Helicobacter pylori Eradication with Standard Triple Therapy and Concomitant Therapy: A Retrospective Study
by: Moon Won Lee, et al.
Published: (2018-06-01) -
Is Only Clarithromycin Susceptibility Important for the Successful Eradication of <i>Helicobacter pylori</i>?
by: Young Min Kim, et al.
Published: (2020-09-01) -
Impact of Different <i>Helicobacter pylori</i> Eradication Therapies on Gastrointestinal Symptoms
by: Antonio Mestrovic, et al.
Published: (2021-08-01)